Comparison of Outcomes Between the Use of Silverlon® Dressing and AQUACEL® AG Dressing Post Cardiac Device Implant

Status: Completed
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to learn how effective each of the two dressings, Silverlon® and AQUACEL® AG, are in preventing post cardiac implantable electronic devices (CIED) procedure wound infections.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients who are scheduled for a CIED implant, generator change, or upgrade at the University of Kansas Hospital

• Able to give informed consent

Locations
United States
Kansas
University of Kansas Medical Center
Kansas City
Time Frame
Start Date: 2016-06
Completion Date: 2017-12
Participants
Target number of participants: 147
Treatments
Active_comparator: Silverlon®
Subjects randomized to this arm will receive Silverlon® dressing postoperative.
Active_comparator: AQUACEL® AG
Subjects randomized to this arm will receive AQUACEL® AG dressing postoperative.
Sponsors
Leads: Kansas City Heart Rhythm Institute

This content was sourced from clinicaltrials.gov